The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan Use
Open accessAbstract
BACKGROUND: The eosinophilia-myalgia syndrome is a newly recognized illness that has been associated with the consumption of tryptophan products. It is not known whether the cause is related to the tryptophan itself or to chemical constituents introduced by the manufacturing process. METHODS: To describe the epidemiology of the eosinophilia-myalgia syndrome further and elucidate a possible association with the manufacturing process, we conducted surveillance for the syndrome in Minnesota, a community survey of tryptophan use in Minneapolis-St. Paul, and a case-control study to assess potential risk factors, including the use of tryptophan from different manufacturers. We performed high-performance liquid chromatography on tryptophan samples to identify other chemical constituents. RESULTS: The prevalence of tryptophan use increased from 1980 to 1989 and was highest among women. Among the subjects for whom the source of the tryptophan was known, 29 of 30 case patients (97 percent) and 21 of 35 controls (60 percent) had consumed tryptophan manufactured by a single company (odds ratio, 19.3; 95 percent confidence interval, 2.5 to 844.9; P less than 0.001). This company used a fermentation process involving Bacillus amyloliquefaciens to manufacture tryptophan. Analysis of the manufacturing conditions according to the retail lot demonstrated an association between lots used by case patients and the use of reduced quantities of powdered carbon in a purification step (odds ratio, 9.0; 95 percent confidence interval, 1.1 to 84.6; P = 0.014), as well as the use of a new strain of B. amyloliquefaciens (Strain V) (odds ratio, 6.0; 95 percent confidence interval, 0.8 to 51.8; P = 0.04). There was a significant correlation (r = 0.78, P less than 0.001) between the reduced amount of powdered carbon used during manufacturing and the use of the new bacterial strain. High-performance liquid chromatography of this company's tryptophan demonstrated one absorbance peak (peak E) that was present in 9 of the 12 retail lots (75 percent) used by patients and 3 of 11 lots (27 percent) used by controls (odds ratio, 8.0; 95 percent confidence interval, 0.9 to 76.6; P = 0.022). CONCLUSIONS: The outbreak of the eosinophilia-myalgia syndrome in 1989 resulted from the ingestion of a chemical constituent that was associated with specific tryptophan-manufacturing conditions at one company. The chemical constituent represented by peak E may contribute to the pathogenesis of the eosinophilia-myalgia syndrome, or it may be a surrogate for another chemical that induces the syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,988
Warde, W. D., Scheaffer, R. L., Mendenhall, W., & Ott., L. (1987) · Technometrics · doi:10.2307/1269791 · Cited by 961
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90044-t · Cited by 409
Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of Tryptophan
Hertzman, P. A., Blevins, W. L., Mayer, J., Greenfield, B., Ting, M., & Gleich, G. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221301 · Cited by 366
Self-citationTOXIC-ALLERGIC SYNDROME CAUSED BY INGESTION OF RAPESEED OIL DENATURED WITH ANILINE
Manuel Tabuenca, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90949-1 · Cited by 319
Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of Tryptophan
Silver, R. M., Heyes, M. P., Maize, J. C., Quearry, B., Vionnet-Fuasset, M., & Sternberg, E. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221302 · Cited by 245
Induction of Tryptophan Degradation In Vitro and In Vivo : A γ-Interferon-Stimulated Activity
BYRNE, G. I., LEHMANN, L. K., KIRSCHBAUM, J. G., BORDEN, E. C., LEE, C. M., & BROWN, R. R. (1986) · Journal of Interferon Research · doi:10.1089/jir.1986.6.389 · Cited by 183
L-tryptophan and eosinophilia-myalgia syndrome in New Mexico
Eidson, M., Sewell, C. M., Voorhees, R. E., Philen, R. M., & Kilbourne, E. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)90421-z · Cited by 115
Tryptophan-Associated Eosinophilic Connective-Tissue Disease: A New Clinical Entity?
Clauw, D. J. (1990) · JAMA · doi:10.1001/jama.1990.03440110068030 · Cited by 84
Cited by
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
Mellor, A. L., & Munn, D. H. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01520-0 · Cited by 648
The Stress Response and the Regulation of Inflammatory Disease
Sternberg, E. M., Chrousos, G. P., Wilder, R. L., & Gold, P. W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-854 · Cited by 470
A National Outbreak of Salmonella enteritidis Infections from Ice Cream
Hennessy, T. W., Hedberg, C. W., Slutsker, L., White, K. E., Besser-Wiek, J. M., Moen, M. E., Feldman, J., Coleman, W. W., Edmonson, L. M., MacDonald, K. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605163342001 · Cited by 389
Self-citationLeukemia and the disruption of normal hematopoiesis
Sawyers, C. L., Denny, C. T., & Witte, O. N. (1991) · Cell · doi:10.1016/0092-8674(91)90643-d · Cited by 343
Maffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010181 · Cited by 236
Metadata
- Authors
- Belongia, E. A., Hedberg, C. W., Gleich, G. J., White, K. E., Mayeno, A. N., Loegering, D. A., Dunnette, S. L., Pirie, P. L., MacDonald, K. L., & Osterholm, M. T.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-08-09
- Volume
- 323
- Issue
- 6
- Pages
- 357-365
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1979384741
- Cited by
- 357
- References
- 13
- FWCI
- 43.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan Use. https://app.cochat.ai/papers/10.1056/nejm199008093230601
- The paper
- Belongia, E. A., Hedberg, C. W., Gleich, G. J., White, K. E., Mayeno, A. N., Loegering, D. A., Dunnette, S. L., Pirie, P. L., MacDonald, K. L., & Osterholm, M. T. (1990). An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan Use. New England Journal of Medicine. https://doi.org/10.1056/nejm199008093230601
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.